Welcome to our dedicated page for Charlie S Holdin news (Ticker: CHUC), a resource for investors and traders seeking the latest updates and insights on Charlie S Holdin stock.
Charlie’s Holdings, Inc. reports developments in premium vapor products and electronic nicotine delivery systems. The company sells product lines including SBX, Pachamama and PACHA through distributors, specialty retailers and online resellers, with operating activity tied to Charlie’s Chalk Dust, LLC.
Recurring updates center on FDA Premarket Tobacco Product Applications, state vapor-product requirements, age-verification technology for device activation, product-line distribution, trade-show participation, financial results and capital actions such as private placements and debt forgiveness.
Charlie's Holdings (OTCQB:CHUC) announced that Board member Dr. Ed Carmines was selected as a panelist for the FDA Roundtable on PMTA submissions for ENDS held February 10, 2026 at FDA headquarters.
Dr. Carmines will discuss pharmacokinetic studies and adult-benefit data for Charlie's PACHA™ disposable e-cigarette, and the roundtable will be viewable online.
Charlie's Holdings (OTCQB:CHUC) will present at two investor conferences in January 2026 as the company pursues an uplist to a national exchange. Presentations by President Henry Sicignano are scheduled for Jan 21, 2026 at 10:00 a.m. EST at the Sequire Investor Summit in Puerto Rico and Jan 28, 2026 at 11:30 a.m. EST at the Deal Flow Discovery Conference in Atlantic City.
The company says it is profitable, growing, has a clean balance sheet with no outstanding warrants and very little debt, and is monetizing SBX, U.S.-filled Pachamama sales and PMTA-submitted PACHA synthetic nicotine products to meet uplist requirements. Individual investor meetings are available by email to suzanne@chuc.com.
Charlie's Holdings (OTCQB: CHUC) announced a strategic licensing agreement with IKE Tech on January 6, 2026 to integrate IKE's AI-powered, blockchain-based age-gating platform into Charlie's SBX product line.
The deal delivers IKE BLE chips and a white-labeled web app, includes a limited exclusivity period for Charlie's nicotine analogue products, and references an IKE FDA-submitted platform that reportedly achieved 100% effectiveness in clinical validation studies at preventing underage activation. Integration into FDA-regulated ENDS devices is planned upon receiving marketing authorization.
Charlie's Holdings (OTCQB:CHUC) signed a definitive license with IKE Tech to commercialize an AI-powered, blockchain-based age-gating system for vape products and will test market the system this spring with its SBX nicotine analogue line while also planning integration into PACHA ENDS.
Key claims include a multi-center Human Factors Validation Study reporting 100% age verification, 0% underage activation, and 100% automatic deactivation. The agreement grants three-year exclusivity for age-gated nicotine analogue products and is positioned to address FDA youth-access priorities.
Charlie's Holdings (OTCQB:CHUC) opened its first US manufacturing facility in Huntington Beach, California and this week began shipping its US-filled Pachamama 25K disposables to 300 retail stores in Texas. The US-filling operation is designed to meet new state domestic-manufacturing requirements effective Sept 1, 2025, allowing Charlie's to sell products to Texas and other states with similar laws.
Management said it will devote 100% of current US manufacturing capacity to Texas and expects strong demand that could materially affect 2026 sales if US capacity is expanded.
Charlie's Holdings (OTCQB: CHUC) reported Q3 2025 revenue of $7.1 million, a 336% increase versus Q3 2024, and returned to profitability with net income of $0.6 million versus a $1.0 million loss a year earlier. Gross profit was $1.8 million (24.9% margin). The company said SBX rollout began in seven states and now represents the majority of sales. Charlie's completed a $1.0 million PMTA asset sale in August, bringing PMTA-related proceeds to $7.5 million with $4.2 million contingent. Cash was $1.1 million and total assets $10.6 million. Management expects continued growth and a US filling line opening in Q4 2025.
Charlies Holdings (OTCQB:CHUC) announced on November 13, 2025 that it will discontinue sales of all hemp/CBD products and permanently wind down and close its Don Polly division.
The company said the move aims to remove hemp/CBD-related trading restrictions imposed by national exchanges and major U.S. brokers, and to facilitate a potential uplist to a national securities exchange and increase liquidity in Charlies common stock. Management stated Don Polly sales are minor relative to 2026 SBX projections and that the companys non-nicotine SBX disposables are now the primary business focus.
Charlie's Holdings (OTCQB:CHUC) reported it secured more than $6 million in purchase orders at the NACS National Show on October 23, 2025, including a single $4.4 million SBX purchase — the largest sale in company history. Management said the $6 million haul is 3x the company's entire first-quarter sales and represents 75% of 2024 sales. The release highlights accelerating retail distribution for non-nicotine SBX disposables and management's expectation that Q4 2025 will be the company's highest-grossing quarter to date. Company comments also cite a Company-sponsored survey comparing SBX favorably to Juul and project potential for much larger annual sales if SBX attains a fraction of Juul's retail reach.
Charlie's Holdings (OTCQB:CHUC) will exhibit at the NACS 2025 National Show in Chicago on Oct 15–17, 2025 (MAX Distributing Booth #N1440) and will present to investors at the LD Micro Main Event in San Diego on Oct 20, 2025 at 11:00am PST. The company will display its SBX and Pachamama 25K products and offer one-on-one investor meetings by request.
Management said Charlie's is profitable with minimal debt, plans to monetize PMTA-submitted PACHA synthetic nicotine products, and expects growing SBX distribution to support meeting uplist requirements to a national securities exchange. Contact and meeting requests: suzanne@chuc.com or LD Micro registration link.
Charlie's Holdings (OTCQB:CHUC) has secured a favorable $2 million credit facility from independent board member Michael D. King to support inventory purchases for their successful SBX™ product line. The facility includes three tranches ($1M initial, two $500K subsequent) at 13% interest rate with 12-month terms.
The non-dilutive financing comes as SBX sales exceed expectations in Southeast regions. In consumer testing, Charlie's non-nicotine SBX Disposables were preferred over Juul tobacco-flavored vapes by a 15:1 margin. The credit facility is notably shareholder-friendly, featuring no equity conversion rights or warrants, with King (who owns >2.5% of CHUC) indicating potential for additional funding if needed.